Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Patch Clamp01:18

Patch Clamp

Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How does machine learning augment alchemical binding free energy calculations?

Future medicinal chemistry·2025
Same author

Perspectives on current approaches to virtual screening in drug discovery.

Expert opinion on drug discovery·2024
Same author

Prediction of Human Clearance Using In Silico Models with Reduced Bias.

Molecular pharmaceutics·2024
Same author

Recent Advances in Alchemical Binding Free Energy Calculations for Drug Discovery.

ACS medicinal chemistry letters·2023
Same author

How do we further enhance 2D fingerprint similarity searching for novel drug discovery?

Expert opinion on drug discovery·2022
Same author

In Silico Positional Analogue Scanning with Amber GPU-TI.

Journal of chemical information and modeling·2022
Same journal

Integration of virtual and physical screening.

Drug discovery today. Technologies·2024
Same journal

A technical overview of supercritical fluid chromatography-mass spectrometry (SFC-MS) and its recent applications in pharmaceutical research and development.

Drug discovery today. Technologies·2021
Same journal

Mass spectrometry based approaches and strategies in bioanalysis for qualitative and quantitative analysis of pharmaceutically relevant molecules.

Drug discovery today. Technologies·2021
Same journal

Drug discovery from natural products using affinity selection-mass spectrometry.

Drug discovery today. Technologies·2021
Same journal

Editorial for the role(s) of MS in drug research and development.

Drug discovery today. Technologies·2021
Same journal

Fragment-to-lead tailored in silico design.

Drug discovery today. Technologies·2021
See all related articles

Related Experiment Video

Updated: May 13, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.1K

Advances in virtual screening.

Ingo Muegge1, Scott Oloff1

  • 1Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, P.O. Box 368, CT 06877-368, USA.

Drug Discovery Today. Technologies
|April 15, 2024
PubMed
Summary
This summary is machine-generated.

Virtual screening, an in silico method for drug discovery, is now essential in the pharmaceutical industry. Recent advancements focus on combining diverse virtual screening techniques to identify new drug leads effectively.

More Related Videos

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.2K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.8K

Related Experiment Videos

Last Updated: May 13, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.1K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.2K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.8K

Area of Science:

  • Computational chemistry and cheminformatics
  • Drug discovery and development
  • Pharmacology

Background:

  • Virtual screening (VS) has emerged as a powerful computational tool for identifying potential drug candidates.
  • The pharmaceutical industry widely employs VS as an in silico analog of high-throughput screening (HTS).
  • Numerous VS methods have been developed, leveraging expanding databases of target structures and assay data.

Purpose of the Study:

  • To highlight the evolution and current status of virtual screening in drug discovery.
  • To emphasize the importance of integrating diverse VS methodologies.
  • To discuss recent developments in optimizing lead identification strategies.

Main Methods:

  • Review and synthesis of existing virtual screening techniques.
  • Analysis of computational approaches for lead identification.
  • Exploration of data mining and machine learning in drug discovery.

Main Results:

  • Virtual screening is a mature and indispensable technique in modern drug discovery.
  • Synergistic application of multiple VS methods enhances the efficiency of lead identification.
  • Ongoing research focuses on combining different computational approaches for improved performance.

Conclusions:

  • Virtual screening plays a critical role in accelerating the identification of novel drug leads.
  • Integrating diverse virtual screening strategies represents a key advancement in the field.
  • The continued development of computational methods promises to further revolutionize drug discovery.